Literature DB >> 12974672

Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Antje K Kretzschmar1, Michaela C Dinger, Christian Henze, Katja Brocke-Heidrich, Friedemann Horn.   

Abstract

Signal transducer and activator of transcription 3 (Stat3) dimerization is commonly thought to be triggered by its tyrosine phosphorylation in response to interleukin-6 (IL-6) or other cytokines. Accumulating evidence from in vitro studies, however, suggests that cytoplasmic Stat3 may be associated with high-molecular-mass protein complexes and/or dimerize prior to its activation. To directly study Stat3 dimerization and subcellular localization upon cytokine stimulation, we used live-cell fluorescence spectroscopy and imaging microscopy combined with fluorescence resonance energy transfer (FRET). Stat3 fusion proteins with spectral variants of green fluorescent protein (GFP), cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) were constructed and expressed in human hepatoma cells (HepG2) and human embryonic kidney cells (HEK-293). Like wild-type Stat3, the fusion proteins redistributed from a preferentially cytoplasmic to nuclear localization upon IL-6 stimulation and supported IL-6-dependent target gene expression. FRET studies in cells co-expressing Stat3-CFP and Stat3-YFP demonstrated that Stat3 dimers exist in the absence of tyrosine phosphorylation. IL-6 induced a 2-fold increase of this basal FRET signal, indicating that tyrosine phosphorylation either increases the dimer/monomer ratio of Stat3 or induces a conformational change of the dimer yielding a higher FRET efficiency. Studies using a mutated Stat3 with a non-functional src-homology 2 (SH2) domain showed that the SH2 domain is essential for dimer formation of phosphorylated as well as non-phosphorylated Stat3. Furthermore, our data show that visualization of normalized FRET signals allow insights into the spatiotemporal dynamics of Stat3 signal transduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 12974672      PMCID: PMC1223859          DOI: 10.1042/BJ20030708

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells.

Authors:  Klaus Podar; Yu-Tzu Tai; Craig E Cole; Teru Hideshima; Martin Sattler; Angela Hamblin; Nicholas Mitsiades; Robert L Schlossman; Faith E Davies; Gareth J Morgan; Nikhil C Munshi; Dharminder Chauhan; Kenneth C Anderson
Journal:  J Biol Chem       Date:  2002-12-12       Impact factor: 5.157

3.  The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.

Authors:  S Gupta; H Yan; L H Wong; S Ralph; J Krolewski; C Schindler
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

4.  Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever.

Authors:  Mehul Shah; Kirit Patel; Victor A Fried; Pravin B Sehgal
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

5.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

6.  The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements.

Authors:  J Yuan; U M Wegenka; C Lütticken; J Buschmann; T Decker; C Schindler; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

Authors:  C Lütticken; U M Wegenka; J Yuan; J Buschmann; C Schindler; A Ziemiecki; A G Harpur; A F Wilks; K Yasukawa; T Taga
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

8.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

Authors:  N Stahl; T G Boulton; T Farruggella; N Y Ip; S Davis; B A Witthuhn; F W Quelle; O Silvennoinen; G Barbieri; S Pellegrini
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

9.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.

Authors:  K Shuai; C M Horvath; L H Huang; S A Qureshi; D Cowburn; J E Darnell
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

10.  Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level.

Authors:  U M Wegenka; J Buschmann; C Lütticken; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

View more
  36 in total

1.  Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.

Authors:  Laura A Ekas; Timothy J Cardozo; Maria Sol Flaherty; Elizabeth A McMillan; Foster C Gonsalves; Erika A Bach
Journal:  Dev Biol       Date:  2010-05-23       Impact factor: 3.582

2.  Intracellular protein interaction mapping with FRET hybrids.

Authors:  Xia You; Annalee W Nguyen; Abeer Jabaiah; Mark A Sheff; Kurt S Thorn; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

3.  Molecular tools for cell and systems biology.

Authors:  Carsten Schultz
Journal:  HFSP J       Date:  2007-11-29

4.  Structural characterization of unphosphorylated STAT5a oligomerization equilibrium in solution by small-angle X-ray scattering.

Authors:  Pau Bernadó; Yolanda Pérez; Jascha Blobel; Juan Fernández-Recio; Dmitri I Svergun; Miquel Pons
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

5.  Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.

Authors:  Ralf Buettner; Renzo Corzano; Rumana Rashid; Jianping Lin; Maheswari Senthil; Michael Hedvat; Anne Schroeder; Allen Mao; Andreas Herrmann; John Yim; Hongzhi Li; Yate-Ching Yuan; Kenichi Yakushijin; Fumiko Yakushijin; Nagarajan Vaidehi; Roger Moore; Gabriel Gugiu; Terry D Lee; Richard Yip; Yuan Chen; Richard Jove; David Horne; John C Williams
Journal:  ACS Chem Biol       Date:  2011-02-16       Impact factor: 5.100

Review 6.  Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer.

Authors:  Sarah R Walker; Michael Xiang; David A Frank
Journal:  Mol Cell Endocrinol       Date:  2013-03-24       Impact factor: 4.102

7.  Protein interaction quantified in vivo by spectrally resolved fluorescence resonance energy transfer.

Authors:  Valerică Raicu; David B Jansma; R J Dwayne Miller; James D Friesen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

Review 8.  Paradigm shifts in the cell biology of STAT signaling.

Authors:  Pravin B Sehgal
Journal:  Semin Cell Dev Biol       Date:  2008-07-24       Impact factor: 7.727

Review 9.  Regulation of STAT signaling by acetylation.

Authors:  Shougang Zhuang
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

Review 10.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.